(92 days)
Not Found
No
The description focuses on physical filtration and ionization processes, and explicitly states "Mentions AI, DNN, or ML: Not Found". The "auto-mode" mentioned is a common feature in many devices and doesn't necessarily imply AI/ML.
Yes.
The "Intended Use / Indications for Use" section states: "The Airdog X8 Air Purifier is a mobile air cleaner intended to remove particles from the air for medical purposes." This explicitly indicates a therapeutic intent.
No
The device is an air purifier intended to remove particles from the air, not to diagnose medical conditions or diseases.
No
The device description clearly outlines multiple hardware components including a pre-filter, ionization frame, ionization field, collecting plates, carbon filter, PCB modules, device status indicators, power switch, and a display panel. It is powered by an AC wall outlet. While software is mentioned in the performance studies, the device itself is a physical air purifier with integrated hardware.
Based on the provided information, the Airdog X8 Air Purifier is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, treatment, or prevention of disease.
- Airdog X8 Function: The Airdog X8 is an air cleaner. Its function is to remove particles and inactivate biological agents from the air in a room. It does not interact with or analyze specimens from the human body.
- Intended Use: The intended use clearly states it's a "mobile air cleaner intended to remove particles from the air for medical purposes." This aligns with an air purification function, not an IVD function.
- Device Description: The description details the air filtration process and components, all related to air cleaning.
- Performance Studies: The performance studies focus on the device's ability to reduce particles and inactivate biological agents in the air, not on analyzing biological specimens.
While the device has a medical purpose (removing particles and inactivating biological agents from the air to potentially benefit health), this purpose is achieved through air purification, not through the in vitro examination of human specimens.
N/A
Intended Use / Indications for Use
The Airdog X8 Air Purifier is a mobile air cleaner intended to remove particles from the air for medical purposes. The device is intended for indoor use only. The Airdog X8 has been demonstrated to effectively inactivate H3N2 and reduce Staphylococcus albus by 4 log with L5 speed.
Product codes (comma separated list FDA assigned to the subject device)
FRF
Device Description
The Airdog X8 Air Purifier (X8) is a mobile air cleaner. The air from the room enters the X8 and passes a pre-filter, ionization frame, ionization field, collecting plates and carbon filter that captures particular matter and biological agents from the air. The X8 contains multiple PCB modules, device status indicators, power switch and a display panel, it allows user to select between different operation parameters, including auto-mode, sleep mode and wind speed. The Ionization wireframe and the collecting plate can be cleaned routinely and are reusable. X8 is powered from an AC wall outlet. It is intended to be used indoors only. The device is not intended to be connected to other instruments or medical devices.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Bench tests show that the X8 produces 4-log reduction of particles, 4-log elimination ratio of total bacteria counts, a 4-log reduction in H3N2 Influenza virus and produce ozone emission which meets the requirements of UL867 for ozone and USA CRB.
Software verification and validation testing were conducted as recommended by FDA's Guidance for Industry and FDA Staff, “Guidance for the Content of Pre-market Submission for Software Contained in Medical Devices.”
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
H3N2 Influenza virus reduced by 99.99% with operation with L5 speed.
Produces a 4-log reduction in PM2.5 particles in 120 minutes in a 30m3 chamber.
Meet the requirements of UL867(
§ 880.5045 Medical recirculating air cleaner.
(a)
Identification. A medical recirculating air cleaner is a device used to remove particles from the air for medical purposes. The device may function by electrostatic precipitation or filtration.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health and Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
June 14, 2024
Suzhou Beiang Smart Technology Co., Ltd. % Chung Lun Chen Regulatory Consultant Lexnovia Venture Studio Ltd. 1F, No. 10, Lane 10, Section 3, Zhongxiao E. Road Da'an District Taipei, 106083 Taiwan
Re: K240696
Trade/Device Name: Airdog X8 Air Purifier (KJ800F-X8) Regulation Number: 21 CFR 880.5045 Regulation Name: Medical Recirculating Air Cleaner Regulatory Class: Class II Product Code: FRF Dated: May 16, 2024 Received: May 16, 2024
Dear Chung Lun Chen:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Christopher K. Dugard -S
Christopher K. Dugard, M.S. Assistant Director DHT4B: Division of Infection Control
2
and Plastic and Reconstructive Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
3
Indications for Use
510(k) Number (if known) K240696
Device Name Airdog X8 Air Purifier (KJ800F-X8)
Indications for Use (Describe)
The Airdog X8 Air Purifier is a mobile air cleaner intended to remove particles from the air for medical purposes. The device is intended for indoor use only. The Airdog X8 has been demonstrated to effectively inactivate H3N2 and reduce Staphylococcus albus by 4 log with L5 speed.
Type of Use (Select one or both, as applicable) |
---|
------------------------------------------------- |
☐ Prescription Use (Part 21 CFR 801 Subpart D) | ☑ Over-The-Counter Use (21 CFR 801 Subpart C) |
---|---|
-------------------------------------------------------------- | ------------------------------------------------------------- |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
K240696 510(k) Summary
Date | Mar 14, 2024 |
---|---|
Manufacturer/ 510(k) | |
Owner | Suzhou Beiang Smart Technology Co., Ltd. |
175#, SONGBEI ROAD, SUZHOU INDUSTRIAL PARK, | |
JIANGSU PROVINCE, 215000, CHINA | |
Contact Person | Yan Zhang |
Phone: +86-18626114866 | |
E-mail: yan@beiantech.com | |
Device Trade Name | |
Common Name | |
Classification Name | |
Device Class | |
Review Panel | |
Regelation Number | |
Product Code | Airdog X8 Air Purifier (KJ800F-X8) |
Air Purifier/ Medical Recirculating Air Cleaner | |
Cleaner, Air, Medical Recirculating | |
II | |
General Hospital | |
880.5045 | |
FRF | |
Device Description and | |
Technology Characteristics | The Airdog X8 Air Purifier (X8) is a mobile air cleaner. The |
air from the room enters the X8 and passes a pre-filter, | |
ionization frame, ionization field, collecting plates and | |
carbon filter that captures particular matter and biological | |
agents from the air. The X8 contains multiple PCB modules, | |
device status indicators, power switch and a display panel, it | |
allows user to select between different operation | |
parameters, including auto-mode, sleep mode and wind | |
speed. | |
The lonization wireframe and the collecting plate can be | |
cleaned routinely and are reusable. X8 is powered from an | |
AC wall outlet. It is intended to be used indoors only. The | |
device is not intended to be connected to other instruments | |
or medical devices. | |
Models | KJ800F-X8 |
Indications for Use | The Airdog X8 Air Purifier is a mobile air cleaner intended to |
be used to remove particles from the air for medical |
510(k) Summary
5
purposes. The device is intended for indoor use only. The Airdog X8 Air Purifier has been demonstrated to effectively inactivate H3N2 and reduce Staphylococcus albus by 4 log with L5 speed.
- Predicate Device(s) K211507 Airdog X5 Recirculating Air Cleaner (model KJ300F-X5)/ BeiAng Air Tech Ltd.
Summary of Comparison and Technological Characteristics
Proposed Device | Predicate Device | Comparison | |
---|---|---|---|
Device Name | Airdog X8 Air Purifier | Airdog X5 Recirculating | |
Air Cleaner (model | |||
KJ300F-X5) | - | ||
510(k) # | K240696 | K211507 | |
Applicant | Suzhou Beiang Smart | ||
Technology Co., Ltd. | BeiAng Air Tech Ltd. | Same | |
Product code | FRF (21 CFR 880.5045) | FRF (21 CFR 880.5045) | Same |
Classification | II | II | Same |
OTC use | YES | YES | Same |
Intended Use | The Airdog X8 Air Purifier is a | ||
mobile air cleaner intended to | |||
be used to remove particles | |||
from the air for medical | |||
purposes. The device is | |||
intended for indoor use only. | |||
The Airdog X8 has been | |||
demonstrated to effectively | |||
inactivate H3N2 and reduce | |||
Staphylococcus albus by 4 | |||
log with L5 speed. | The Airdog is a mobile air | ||
cleaner intended to be used | |||
to remove particles from the | |||
air for medical purposes. | |||
The device is intended for | |||
indoor use only. | |||
The Airdog has been | |||
demonstrated to effectively | |||
inactivate H3N2 and reduce | |||
Staphylococcus albus by 4 | |||
log with L4 speed. | Same. | ||
Both devices are | |||
room | |||
recirculating air | |||
cleaners for | |||
medical purpose. | |||
Use | |||
Environment | indoor | indoor | Same |
Technology | Air from the room is passed | ||
through a plasma-ion field to | |||
neutralize airborne micro- | |||
organisms. | |||
negative | |||
a | |||
charged | |||
dust | |||
collecting | |||
electrode traps the resulting | |||
debris and a third carbon | |||
absorbs any ozone | |||
stage | |||
generated as a byproduct. | |||
(ETL test results also show | |||
that even if the carbon net is | |||
removed, the ozone is lower | |||
regulatory | |||
than | |||
the | |||
requirements) | Air from the room is passed | ||
through a plasma-ion field to | |||
neutralize airborne micro- | |||
organisms. | |||
negative | |||
a | |||
charged dust collecting | |||
electrode traps the resulting | |||
debris and a third carbon | |||
stage absorbs any ozone | |||
generated as a byproduct. | |||
(ETL test results also show | |||
that even if the carbon net is | |||
removed, the ozone is lower | |||
regulatory | |||
than | |||
the | |||
requirements) | Same | ||
Power Source | 100-240V~50-60Hz | 100-240V~50-60Hz | Same |
Weight(kg) | 19.7 | 10.7 | Different |
Dimension | 29.92 inch (H) x 14.96 inch | ||
(W) x 14.96 inch (L) | 25.59 inch (H) x 12.04 | ||
inch (W) x 12.44 inch (L) | Different | ||
Reduction of | |||
biological | |||
agents | H3N2 Influenza virus | ||
reduced by 99.99% | |||
with operation with L5 speed | H3N2 Influenza virus | ||
reduced by 99.99% | |||
with operation with L4 | |||
speed | Similar | ||
Filtration of | |||
particles | Produces a 4-log reduction in | ||
PM2.5 particles | |||
in 120 minutes in a 30m3 | |||
chamber | Produces a 4-log reduction | ||
in PM2.5 particles | |||
in 120 minutes in a 30m3 | |||
chamber | Same | ||
Ozone | |||
emitted | Meet the requirements of | ||
UL867( |